CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 64 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2021$211,0000.0%94,996
+11.8%
0.00%
Q4 2020$211,000
+1.0%
84,9370.0%0.00%
Q3 2020$209,000
-30.8%
84,9370.0%0.00%
Q2 2020$302,000
+153.8%
84,937
+40.6%
0.00%
Q1 2019$119,000
+48.8%
60,4000.0%0.00%
Q4 2018$80,000
-46.3%
60,4000.0%0.00%
Q3 2018$149,000
-12.4%
60,400
+19.8%
0.00%
Q2 2018$170,000
-20.6%
50,4000.0%0.00%
Q1 2018$214,000
+28.1%
50,4000.0%0.00%
Q4 2017$167,000
-13.5%
50,4000.0%0.00%
Q3 2017$193,000
-13.1%
50,4000.0%0.00%
Q2 2017$222,00050,4000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders